Table 3.
Effects of alfaxalone (10 nM–10 μM) on spontaneous glycinergic IPSCs.
| Alfaxalone concentration | Amplitude (pA) | Frequency (Hz) | 10%–90% rise-time (ms) | Half-width (ms) |
|---|---|---|---|---|
| Control | −52 (−77 to −28) | 1.01 (0.46–2.68) | 7.6 (4.2–10.9) | 7.2 (3.8–10.7) |
| 10 nM | −47 (−72 to– 22) | 1.00 (0.42–2.68) | 7.1 (5–9.2) | 7.1 (4–10.1) |
| 30 nM | −45.5 (−63 to −28) | 0.71 (0.29–2.58) | 4.4 (2.9–5.9) | 7.1 (3.7–10.5) |
| 100 nM | −45 (−75 to −17) | 0.66 (0.12–2.67) | 4.4 (3.2–5.5) | 6.9 (4.3–9.4) |
| 300 nM | −44 (−58 to −27) | 0.64 (0.10–2.3) | 4.6 (3.3–5.9) | 7 (4.7–9.3) |
| 1 μM | −44 (−52 to −33) | 0.57 (0.2–2.22) | 4.2 (3.3–5.2) | 8 (4.6–11.8) |
| 3 μM | −35 (−44 to −27) | 0.44* (0.3–0.88) | 6.1 (3.9–8.3) | 5.8 (3.8–7.8) |
| 10 μM | −31 (−40 to −21) | 0.21* (0.14–0.45) | 6.9 (5.4–8.5) | 4.8 (2.8–6.9) |
Mean ± 95% CI, n = 7 HMNs. Repeated measures ANOVA, Dunnett’s test. *P < 0.05.